Ledger.Open graph →
SEC Form D · filed May 29, 2020

PLx Pharma Inc

Offering
$8.0M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SPARTA, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

John W. Hadden Ii · HOUSTON, TXDirectorNatasha Giordano · Hoboken, NJExec · DirectorGary J. Balkema · HOUSTON, TXDirectorRita O'Connor · HOUSTON, TXExecKirk J. Calhoun · HOUSTON, TXDirectorAnthony J. Bartsh · SPARTA, NJDirectorMichael J. Valentino · Denver, COExec · DirectorRobert J. Casale · Houston, TXDirectorNatasha Giordano · HOUSTON, TXExec · DirectorGary J. Balkema · HOUSTON, TXDirectorRita O'Connor · HOUSTON, TXExecKirk J. Calhoun · HOUSTON, TXDirectorJohn W. Hadden Ii · HOUSTON, TXDirectorAnthony J. Bartsh · SPARTA, NJDirectorMichael J. Valentino · DUBLIN, CAExec · DirectorRobert J. Casale · Houston, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗